These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26223091)

  • 1. Autoimmune Pitfalls of Anti-Tumor Necrosis Factor-Alpha Therapy.
    Roginić S; Jelić A; Stipić-Marković A; Marinko A; Artuković IN; Dušanka MK
    Isr Med Assoc J; 2015 Feb; 17(2):117-9. PubMed ID: 26223091
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful Etanercept Treatment for Primary Biliary Cirrhosis Associated with Rheumatoid Arthritis.
    Kovács A; Siminischi AG; Baksay B; Gáll A; Takács M; Szekanecz Z
    Isr Med Assoc J; 2015 Feb; 17(2):114-6. PubMed ID: 26223090
    [No Abstract]   [Full Text] [Related]  

  • 3. Etanercept-Induced Pneumonitis: Severe Complication of Tumor Necrosis Factor-Alpha Blocker Treatment.
    Watad A; Perelman M; Mansour R; Shoenfeld Y; Amital H
    Isr Med Assoc J; 2015 Feb; 17(2):130-2. PubMed ID: 26223096
    [No Abstract]   [Full Text] [Related]  

  • 4. Graves' disease, rheumatoid arthritis, and anti-tumor necrosis factor-alpha therapy.
    Shin JI; Kim MJ; Lee JS
    J Rheumatol; 2009 Feb; 36(2):449-50; author reply 450. PubMed ID: 19208577
    [No Abstract]   [Full Text] [Related]  

  • 5. Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease.
    Richez C; Blanco P; Dumoulin C; Schaeverbeke T
    Clin Exp Rheumatol; 2005; 23(2):273. PubMed ID: 15895904
    [No Abstract]   [Full Text] [Related]  

  • 6. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept and methotrexate in rheumatoid arthritis.
    Malgarini RB; Pimpinella G
    Lancet; 2004 May; 363(9422):1733; author reply 1733. PubMed ID: 15158641
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
    Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
    Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
    [No Abstract]   [Full Text] [Related]  

  • 10. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
    Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
    CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraplegia in a patient receiving anti-tumor necrosis factor therapy for rheumatoid arthritis: comment on the article by Mohan et al.
    van der Laken CJ; Lems WF; van Soesbergen RM; van der Sande JJ; Dijkmans BA
    Arthritis Rheum; 2003 Jan; 48(1):269-70. PubMed ID: 12528130
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced systemic lupus erythematosus associated with etanercept therapy.
    Shakoor N; Michalska M; Harris CA; Block JA
    Lancet; 2002 Feb; 359(9306):579-80. PubMed ID: 11867114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 15. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
    Cairns AP; Duncan MK; Hinder AE; Taggart AJ
    Ann Rheum Dis; 2002 Nov; 61(11):1031-2. PubMed ID: 12379532
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.
    Furst DE; Weisman M; Paulus HE; Bulpitt K; Weinblatt M; Polisson R; Zaug M; Kneer J; Van der Auwera P; Stevens RM
    J Rheumatol; 2003 Oct; 30(10):2123-6. PubMed ID: 14528504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphopenia induced by etanercept.
    Pepper AN; Talreja N; Cowan GM; Glaum MC; Lockey RF
    Ann Allergy Asthma Immunol; 2014 Mar; 112(3):262-3. PubMed ID: 24565596
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
    Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in psoriatic patients treated with anti-TNF-α therapy.
    Bardazzi F; Odorici G; Virdi A; Antonucci VA; Tengattini V; Patrizi A; Balestri R
    J Dtsch Dermatol Ges; 2014 May; 12(5):401-6. PubMed ID: 24797746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.